Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.

Marco Marcelli, S. Zoppi, Carol M. Wilson, Jim E. Griffin, Michael J. McPhaulJournal of Clinical Investigation 1994 · DOI

Abstract

We have investigated the basis of androgen resistance in seven unrelated individuals with complete testicular feminization or Reifenstein syndrome caused by single amino acid substitutions in the hormone-binding domain of the androgen receptor. Monolayer-binding assays of cultured genital skin fibroblasts demonstrated absent ligand binding, qualitative abnormalities of androgen binding, or a decreased amount of qualitatively normal receptor. The consequences of these mutations were examined by introducing the mutations by site-directed mutagenesis into the androgen receptor cDNA sequence and expressing the mutant cDNAs in mammalian cells. The effects of the amino acid substitutions on the binding of different androgens and on the capacity of the ligand-bound receptors to activate a reporter gene were investigated. Substantial differences were found in the responses of the mutant androgen receptors to incubation with testosterone, 5 alpha-dihydrotestosterone, and mibolerone. In several instances, increased doses of hormone or increased frequency of hormone addition to the incubation medium resulted in normal or near normal activation of a reporter gene by cells expressing the mutant androgen receptors. These studies suggest that the stability of the hormone receptor complex is a major determinant of receptor function in vivo.

Introduction

Androgen Insensitivity Syndrome (AIS) encompasses a broad clinical spectrum, ranging from individuals who are phenotypically female (complete testicular feminization) to men with minor fertility issues. While these conditions are known to be caused by mutations in the androgen receptor (AR) gene, the molecular mechanisms underlying the varying clinical severity have remained elusive. Many patients possess receptors that can bind androgens in vitro but fail to function effectively in the body. This study investigates whether the stability of the hormone-receptor complex—how long the hormone remains bound—is the critical variable determining clinical outcomes.

Methods

The researchers employed a dual approach, combining clinical observation with molecular reconstruction:

  1. Patient Fibroblasts: Skin cells from seven unrelated patients with androgen resistance were cultured to observe natural receptor behavior.
  2. Site-Directed Mutagenesis: PCR-based techniques were used to recreate exact patient mutations in a clean AR cDNA sequence.
  3. Heterologous Expression: Mutant receptors were expressed in mammalian cell lines (CHO and CV1) lacking endogenous AR.
  4. Functional Assays: Binding kinetics were measured using radioactive ligands ($[^3H]$DHT and $[^3H]$mibolerone) to determine affinity ($K_d$) and dissociation rates. Transcriptional activation was assessed using an MMTV-luciferase reporter gene under various hormone dosing schedules.

Key Insights: The "Revolving Door" Effect

A primary discovery was the "revolving door" effect observed in several mutants, such as F762L. These receptors showed nearly normal binding affinity but exhibited extremely rapid dissociation. The hormone enters the receptor but falls out before the complex can translocate to the nucleus and bind DNA. This suggests that the duration of the hormone-receptor interaction is a more critical determinant of gene activation than initial binding strength.

Table showing Bmax, Kd, and dissociation rates for various AR mutants. Note the rapid decline in radioactivity remaining for mutants compared to the control (CMV3.1).

Key Results: Stability and Pharmacological Rescue

The study identified several key functional consequences of the mutations:

  • Structural Collapse: The W739R mutation (N-69) resulted in a total loss of binding and function, likely due to the substitution of a bulky residue into the hydrophobic binding pocket.
  • Accelerated Dissociation: While normal receptors retain >60% of bound hormone after 3 hours, several mutants retained significantly less, with some falling below 10% in the same timeframe.
  • Pharmacological Rescue: For some mutants, the functional defect was not absolute. Increasing the concentration of DHT or adding the hormone more frequently (e.g., every 12 hours) significantly restored the receptor's ability to activate genes. For instance, the P764S mutant's activity jumped from 3% to nearly 40% of normal with pulsed dosing.
Table demonstrating the effects of hormone concentration and frequency of addition on the transcriptional induction of a reporter gene by mutant ARs.

Discussion and Limitations

The study concludes that for many AIS patients, the "broken" receptor is actually a "leaky" one, where instability of the hormone-receptor complex prevents proper signaling. This opens potential therapeutic avenues focused on stabilizing these complexes. However, several limitations remain. While high-dose "rescue" works in vitro, achieving such concentrations in vivo without significant side effects is challenging. Furthermore, as this study predates the full resolution of the AR hormone-binding domain crystal structure, modern computational modeling could now provide a more precise map of these structural disruptions. Finally, the small sample size of seven patients makes it difficult to establish a perfect correlation between specific dissociation rates and clinical phenotypes.

Summary updated

Abstract

We have investigated the basis of androgen resistance in seven unrelated individuals with complete testicular feminization or Reifenstein syndrome caused by single amino acid substitutions in the hormone-binding domain of the androgen receptor. Monolayer-binding assays of cultured genital skin fibroblasts demonstrated absent ligand binding, qualitative abnormalities of androgen binding, or a decreased amount of qualitatively normal receptor. The consequences of these mutations were examined by introducing the mutations by site-directed mutagenesis into the androgen receptor cDNA sequence and expressing the mutant cDNAs in mammalian cells. The effects of the amino acid substitutions on the binding of different androgens and on the capacity of the ligand-bound receptors to activate a reporter gene were investigated. Substantial differences were found in the responses of the mutant androgen receptors to incubation with testosterone, 5 alpha-dihydrotestosterone, and mibolerone. In several instances, increased doses of hormone or increased frequency of hormone addition to the incubation medium resulted in normal or near normal activation of a reporter gene by cells expressing the mutant androgen receptors. These studies suggest that the stability of the hormone receptor complex is a major determinant of receptor function in vivo.
BibTeX
@article{marcelli1994amino,
  author = {Marco Marcelli and S. Zoppi and Carol M. Wilson and Jim E. Griffin and Michael J. McPhaul},
  title = {{Amino acid substitutions in the hormone-binding domain of the human androgen receptor alter the stability of the hormone receptor complex.}},
  journal = {Journal of Clinical Investigation},
  year = {1994},
  doi = {10.1172/jci117507},
}
Figure